Trials / Recruiting
RecruitingNCT06380218
Evaluation of Nutritional Prevention Program for Women's Cardiovascular Health on Quality of Life (SAFE)
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Institut Pasteur de Lille · Academic / Other
- Sex
- Female
- Age
- 40 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The objective is to evaluate the effect of a nutritional prevention program associated with the consumption of "Primevère margarine" on the quality of life of women at risk of cardiovascular disease after 10 group coaching sessions in nutrition and physical activity.
Detailed description
The objective is to evaluate the effect of a nutritional prevention program associated with the consumption of "Primevère margarine" on the quality of life of women aged 40 to 65 with cardiovascular risk 3 months after 10 group coaching sessions. The nutritional prevention program includes tools and 10 collective workshops to change the life behaviours (eating habits and physical activity) by assessing : * Food balance and diversity * Eating behaviour and representations * Level of knowledge in nutrition * Level of physical activity and physical inactivity * Physical abilities: strength, balance, flexibility, cardio respiratory endurance, recovery capacity * Behavioural barriers and educational levers to improve women's cardiovascular health
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Nutrional and physical activity program | Nutritional prevention and physical activity workshops associated with a substitution of saturated and/or trans fatty acids by cis-unsaturated acids via the consumption of Primevère margarine to influence lifestyle habits, quality of life and improvement of the lipid profile of women with cardiovascular risk |
Timeline
- Start date
- 2023-07-11
- Primary completion
- 2025-03-01
- Completion
- 2025-08-01
- First posted
- 2024-04-23
- Last updated
- 2024-04-23
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06380218. Inclusion in this directory is not an endorsement.